Identification of target genes of the p16INK4A-pRB-E2F pathway - PubMed (original) (raw)
. 2003 Nov 14;278(46):46124-37.
doi: 10.1074/jbc.M304930200. Epub 2003 Aug 15.
Affiliations
- PMID: 12923195
- DOI: 10.1074/jbc.M304930200
Free article
Identification of target genes of the p16INK4A-pRB-E2F pathway
Richard Vernell et al. J Biol Chem. 2003.
Free article
Abstract
Deregulation of the retinoblastoma protein (pRB) pathway is a hallmark of human cancer. The core members of this pathway include the tumor suppressor protein, pRB, which through binding to a number of cellular proteins, most notably members of the E2F transcription factor family, regulates progression through the cell division cycle. With the aim of identifying transcriptional changes provoked by deregulation of the pRB pathway, we have used cell lines that conditionally express a constitutively active phosphorylation site mutant of pRB (pRBDeltaCDK) or p16INK4A (p16). The expression of pRBDeltaCDK and p16 resulted in significant repression and activation of a large number of genes as measured by high density oligonucleotide array analysis. Transcriptional changes were found in genes that are essential for DNA replication and cell proliferation. In agreement with previous results, we found a high degree of overlap between genes regulated by p16 and pRB. Data we have obtained previously for E2F family members showed that 74 of the genes repressed by pRB and p16 were induced by the E2Fs and 23 genes that were induced by pRB and p16 were repressed by the E2Fs. Thus, we have identified 97 genes as physiological targets of the pRB pathway, and the further characterization of these genes should provide insights into how this pathway controls proliferation. We show that Gibbs sampling detects enrichment of several sequence motifs, including E2F consensus binding sites, in the upstream regions of these genes and use this enrichment in an in silico filtering process to refine microarray derived gene lists.
Similar articles
- Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K, Vlach J, Hennecke S, Amati B. Alevizopoulos K, et al. EMBO J. 1997 Sep 1;16(17):5322-33. doi: 10.1093/emboj/16.17.5322. EMBO J. 1997. PMID: 9311992 Free PMC article. - Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
Alevizopoulos K, Sanchez B, Amati B. Alevizopoulos K, et al. Oncogene. 2000 Apr 13;19(16):2067-74. doi: 10.1038/sj.onc.1203534. Oncogene. 2000. PMID: 10803468 - The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA. Dirks PB, et al. Oncogene. 1998 Aug 20;17(7):867-76. doi: 10.1038/sj.onc.1202008. Oncogene. 1998. PMID: 9780003 - [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. Viallard JF, et al. Cancer Radiother. 2001 Apr;5(2):109-29. doi: 10.1016/s1278-3218(01)00087-7. Cancer Radiother. 2001. PMID: 11355576 Review. French. - Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA. Sidle A, et al. Crit Rev Biochem Mol Biol. 1996 Jun;31(3):237-71. doi: 10.3109/10409239609106585. Crit Rev Biochem Mol Biol. 1996. PMID: 8817077 Review.
Cited by
- Author Correction: EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. Bracken AP, et al. EMBO J. 2024 Mar;43(5):886. doi: 10.1038/s44318-024-00033-4. EMBO J. 2024. PMID: 38347304 Free PMC article. - Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex.
Kandhaya-Pillai R, Miro-Mur F, Alijotas-Reig J, Tchkonia T, Schwartz S, Kirkland JL, Oshima J. Kandhaya-Pillai R, et al. Aging (Albany NY). 2023 May 22;15(10):4012-4034. doi: 10.18632/aging.204743. Epub 2023 May 22. Aging (Albany NY). 2023. PMID: 37219418 Free PMC article. - The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations.
Soria-Bretones I, Thu KL, Silvester J, Cruickshank J, El Ghamrasni S, Ba-Alawi W, Fletcher GC, Kiarash R, Elliott MJ, Chalmers JJ, Elia AC, Cheng A, Rose AAN, Bray MR, Haibe-Kains B, Mak TW, Cescon DW. Soria-Bretones I, et al. Sci Adv. 2022 Sep 9;8(36):eabq4293. doi: 10.1126/sciadv.abq4293. Epub 2022 Sep 7. Sci Adv. 2022. PMID: 36070391 Free PMC article. - The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds.
Duan X, Cai Y, He T, Shi X, Zhao J, Zhang H, Shen Y, Zhang H, Zhang H, Duan W, Jiang B, Mao X. Duan X, et al. J Gastrointest Oncol. 2021 Aug;12(4):1786-1796. doi: 10.21037/jgo-21-312. J Gastrointest Oncol. 2021. PMID: 34532128 Free PMC article. - CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
Yunoki T, Hirano T, Tabuchi Y, Furusawa Y, Torigoe M, Nakajima T, Imura J, Hayashi A. Yunoki T, et al. Int Ophthalmol. 2020 Feb;40(2):343-350. doi: 10.1007/s10792-019-01185-7. Epub 2019 Sep 30. Int Ophthalmol. 2020. PMID: 31571090
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources